Global Famitinib Malate Capsules Market Growth 2026-2032
The global Famitinib Malate Capsules market size is predicted to grow from US$ 10.17 million in 2025 to US$ 41.76 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.
Famitinib malate is an oral multi-target tyrosine kinase inhibitor that mainly acts on various kinase targets such as VEGFR, PDGFR, and c-Kit. It exerts anti-tumor effects by inhibiting tumor angiogenesis and blocking signal transduction for tumor cell proliferation. Formulated as oral capsules in the form of malate salt, it is mainly used clinically for the treatment of advanced or metastatic solid tumors. It is often combined with immune checkpoint inhibitors to improve therapeutic efficacy. Characterized by a broad target spectrum, convenient oral administration, and a wide anti-tumor range, it has clear clinical application value in gynecological tumors, gastrointestinal tumors and other fields.In 2025, global production of Famitinib Malate Capsules reached approximately 1.2 million bottles.
Famitinib malate, a Class 1 innovative drug independently developed by Hengrui Medicine, is the world's first multi-target tyrosine kinase inhibitor approved for the treatment of cervical cancer. Centered on the targeted-immunotherapy regimen in combination with camrelizumab, it fills a key gap in the second-line treatment of recurrent or metastatic cervical cancer. Positioned for patients who have not received bevacizumab, it has formed differentiated competitiveness in the domestic cervical cancer treatment field thanks to its convenient oral administration, broad target coverage and remarkable efficacy. Following its inclusion in the National Reimbursement Drug List at the end of 2025, treatment costs dropped significantly, patient accessibility improved substantially, and clinical penetration accelerated. In the current market landscape, as the only domestically approved targeted-immunotherapy combination regimen for cervical cancer, famitinib competes with imported anti-angiogenic agents, domestic similar TKIs and bispecific antibodies. It holds a core position in second-line treatment by virtue of its medical insurance advantages, local R&D strengths and superior survival benefit data. Meanwhile, its ongoing research covers first-line cervical cancer and other solid tumors, which is expected to further expand its market space and consolidate its leading position in the field of oncology therapy.
LP Information, Inc. (LPI) ' newest research report, the ?Famitinib Malate Capsules Industry Forecast? looks at past sales and reviews total world Famitinib Malate Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Famitinib Malate Capsules sales for 2026 through 2032. With Famitinib Malate Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Famitinib Malate Capsules industry.
This Insight Report provides a comprehensive analysis of the global Famitinib Malate Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Famitinib Malate Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Famitinib Malate Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Famitinib Malate Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Famitinib Malate Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Famitinib Malate Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Famitinib Malate Capsules market?
What factors are driving Famitinib Malate Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Famitinib Malate Capsules market opportunities vary by end market size?
How does Famitinib Malate Capsules break out by Type, by Application?
Famitinib malate is an oral multi-target tyrosine kinase inhibitor that mainly acts on various kinase targets such as VEGFR, PDGFR, and c-Kit. It exerts anti-tumor effects by inhibiting tumor angiogenesis and blocking signal transduction for tumor cell proliferation. Formulated as oral capsules in the form of malate salt, it is mainly used clinically for the treatment of advanced or metastatic solid tumors. It is often combined with immune checkpoint inhibitors to improve therapeutic efficacy. Characterized by a broad target spectrum, convenient oral administration, and a wide anti-tumor range, it has clear clinical application value in gynecological tumors, gastrointestinal tumors and other fields.In 2025, global production of Famitinib Malate Capsules reached approximately 1.2 million bottles.
Famitinib malate, a Class 1 innovative drug independently developed by Hengrui Medicine, is the world's first multi-target tyrosine kinase inhibitor approved for the treatment of cervical cancer. Centered on the targeted-immunotherapy regimen in combination with camrelizumab, it fills a key gap in the second-line treatment of recurrent or metastatic cervical cancer. Positioned for patients who have not received bevacizumab, it has formed differentiated competitiveness in the domestic cervical cancer treatment field thanks to its convenient oral administration, broad target coverage and remarkable efficacy. Following its inclusion in the National Reimbursement Drug List at the end of 2025, treatment costs dropped significantly, patient accessibility improved substantially, and clinical penetration accelerated. In the current market landscape, as the only domestically approved targeted-immunotherapy combination regimen for cervical cancer, famitinib competes with imported anti-angiogenic agents, domestic similar TKIs and bispecific antibodies. It holds a core position in second-line treatment by virtue of its medical insurance advantages, local R&D strengths and superior survival benefit data. Meanwhile, its ongoing research covers first-line cervical cancer and other solid tumors, which is expected to further expand its market space and consolidate its leading position in the field of oncology therapy.
LP Information, Inc. (LPI) ' newest research report, the ?Famitinib Malate Capsules Industry Forecast? looks at past sales and reviews total world Famitinib Malate Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Famitinib Malate Capsules sales for 2026 through 2032. With Famitinib Malate Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Famitinib Malate Capsules industry.
This Insight Report provides a comprehensive analysis of the global Famitinib Malate Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Famitinib Malate Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Famitinib Malate Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Famitinib Malate Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Famitinib Malate Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Famitinib Malate Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 5 mg per capsule
- 10 mg per capsule
- Camrelizumab
- Chemotherapeutic Agents
- Innovator
- Generic
- Hospital
- Retail
- Online
- Recurrent or Metastatic Cervical Cancer
- Advanced Gastrointestinal Tumors
- Other Advanced Solid Tumors
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jiangsu Hengrui Pharmaceutical
What is the 10-year outlook for the global Famitinib Malate Capsules market?
What factors are driving Famitinib Malate Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Famitinib Malate Capsules market opportunities vary by end market size?
How does Famitinib Malate Capsules break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Famitinib Malate Capsules Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Famitinib Malate Capsules by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Famitinib Malate Capsules by Country/Region, 2021, 2025 & 2032
2.2 Famitinib Malate Capsules Segment by Type
2.2.1 5 mg per capsule
2.2.2 10 mg per capsule
2.2.3 Famitinib Malate Capsules Sales by Type
2.2.3.1 Global Famitinib Malate Capsules Sales Market Share by Type (2021-2026)
2.2.3.2 Global Famitinib Malate Capsules Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Famitinib Malate Capsules Sale Price by Type (2021-2026)
2.3 Famitinib Malate Capsules Segment by Combination Therapy
2.3.1 Camrelizumab
2.3.2 Chemotherapeutic Agents
2.3.3 Famitinib Malate Capsules Sales by Combination Therapy
2.3.3.1 Global Famitinib Malate Capsules Sales Market Share by Combination Therapy (2021-2026)
2.3.3.2 Global Famitinib Malate Capsules Revenue and Market Share by Combination Therapy (2021-2026)
2.3.3.3 Global Famitinib Malate Capsules Sale Price by Combination Therapy (2021-2026)
2.4 Famitinib Malate Capsules Segment by Production Technology
2.4.1 Innovator
2.4.2 Generic
2.4.3 Famitinib Malate Capsules Sales by Production Technology
2.4.3.1 Global Famitinib Malate Capsules Sales Market Share by Production Technology (2021-2026)
2.4.3.2 Global Famitinib Malate Capsules Revenue and Market Share by Production Technology (2021-2026)
2.4.3.3 Global Famitinib Malate Capsules Sale Price by Production Technology (2021-2026)
2.5 Famitinib Malate Capsules Segment by Sales Channels
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 Famitinib Malate Capsules Sales by Sales Channels
2.5.4.1 Global Famitinib Malate Capsules Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global Famitinib Malate Capsules Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global Famitinib Malate Capsules Sale Price by Sales Channels (2021-2026)
2.6 Famitinib Malate Capsules Segment by Application
2.6.1 Recurrent or Metastatic Cervical Cancer
2.6.2 Advanced Gastrointestinal Tumors
2.6.3 Other Advanced Solid Tumors
2.6.4 Famitinib Malate Capsules Sales by Application
2.6.4.1 Global Famitinib Malate Capsules Sale Market Share by Application (2021-2026)
2.6.4.2 Global Famitinib Malate Capsules Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Famitinib Malate Capsules Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Famitinib Malate Capsules Breakdown Data by Company
3.1.1 Global Famitinib Malate Capsules Annual Sales by Company (2021-2026)
3.1.2 Global Famitinib Malate Capsules Sales Market Share by Company (2021-2026)
3.2 Global Famitinib Malate Capsules Annual Revenue by Company (2021-2026)
3.2.1 Global Famitinib Malate Capsules Revenue by Company (2021-2026)
3.2.2 Global Famitinib Malate Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Famitinib Malate Capsules Sale Price by Company
3.4 Key Manufacturers Famitinib Malate Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Famitinib Malate Capsules Product Location Distribution
3.4.2 Players Famitinib Malate Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FAMITINIB MALATE CAPSULES BY GEOGRAPHIC REGION
4.1 World Historic Famitinib Malate Capsules Market Size by Geographic Region (2021-2026)
4.1.1 Global Famitinib Malate Capsules Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Famitinib Malate Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Famitinib Malate Capsules Market Size by Country/Region (2021-2026)
4.2.1 Global Famitinib Malate Capsules Annual Sales by Country/Region (2021-2026)
4.2.2 Global Famitinib Malate Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Famitinib Malate Capsules Sales Growth
4.4 APAC Famitinib Malate Capsules Sales Growth
4.5 Europe Famitinib Malate Capsules Sales Growth
4.6 Middle East & Africa Famitinib Malate Capsules Sales Growth
5 AMERICAS
5.1 Americas Famitinib Malate Capsules Sales by Country
5.1.1 Americas Famitinib Malate Capsules Sales by Country (2021-2026)
5.1.2 Americas Famitinib Malate Capsules Revenue by Country (2021-2026)
5.2 Americas Famitinib Malate Capsules Sales by Type (2021-2026)
5.3 Americas Famitinib Malate Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Famitinib Malate Capsules Sales by Region
6.1.1 APAC Famitinib Malate Capsules Sales by Region (2021-2026)
6.1.2 APAC Famitinib Malate Capsules Revenue by Region (2021-2026)
6.2 APAC Famitinib Malate Capsules Sales by Type (2021-2026)
6.3 APAC Famitinib Malate Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Famitinib Malate Capsules by Country
7.1.1 Europe Famitinib Malate Capsules Sales by Country (2021-2026)
7.1.2 Europe Famitinib Malate Capsules Revenue by Country (2021-2026)
7.2 Europe Famitinib Malate Capsules Sales by Type (2021-2026)
7.3 Europe Famitinib Malate Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Famitinib Malate Capsules by Country
8.1.1 Middle East & Africa Famitinib Malate Capsules Sales by Country (2021-2026)
8.1.2 Middle East & Africa Famitinib Malate Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Famitinib Malate Capsules Sales by Type (2021-2026)
8.3 Middle East & Africa Famitinib Malate Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Famitinib Malate Capsules
10.3 Manufacturing Process Analysis of Famitinib Malate Capsules
10.4 Industry Chain Structure of Famitinib Malate Capsules
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Famitinib Malate Capsules Distributors
11.3 Famitinib Malate Capsules Customer
12 WORLD FORECAST REVIEW FOR FAMITINIB MALATE CAPSULES BY GEOGRAPHIC REGION
12.1 Global Famitinib Malate Capsules Market Size Forecast by Region
12.1.1 Global Famitinib Malate Capsules Forecast by Region (2027-2032)
12.1.2 Global Famitinib Malate Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Famitinib Malate Capsules Forecast by Type (2027-2032)
12.7 Global Famitinib Malate Capsules Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jiangsu Hengrui Pharmaceutical
13.1.1 Jiangsu Hengrui Pharmaceutical Company Information
13.1.2 Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Product Portfolios and Specifications
13.1.3 Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jiangsu Hengrui Pharmaceutical Main Business Overview
13.1.5 Jiangsu Hengrui Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Famitinib Malate Capsules Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Famitinib Malate Capsules by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Famitinib Malate Capsules by Country/Region, 2021, 2025 & 2032
2.2 Famitinib Malate Capsules Segment by Type
2.2.1 5 mg per capsule
2.2.2 10 mg per capsule
2.2.3 Famitinib Malate Capsules Sales by Type
2.2.3.1 Global Famitinib Malate Capsules Sales Market Share by Type (2021-2026)
2.2.3.2 Global Famitinib Malate Capsules Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Famitinib Malate Capsules Sale Price by Type (2021-2026)
2.3 Famitinib Malate Capsules Segment by Combination Therapy
2.3.1 Camrelizumab
2.3.2 Chemotherapeutic Agents
2.3.3 Famitinib Malate Capsules Sales by Combination Therapy
2.3.3.1 Global Famitinib Malate Capsules Sales Market Share by Combination Therapy (2021-2026)
2.3.3.2 Global Famitinib Malate Capsules Revenue and Market Share by Combination Therapy (2021-2026)
2.3.3.3 Global Famitinib Malate Capsules Sale Price by Combination Therapy (2021-2026)
2.4 Famitinib Malate Capsules Segment by Production Technology
2.4.1 Innovator
2.4.2 Generic
2.4.3 Famitinib Malate Capsules Sales by Production Technology
2.4.3.1 Global Famitinib Malate Capsules Sales Market Share by Production Technology (2021-2026)
2.4.3.2 Global Famitinib Malate Capsules Revenue and Market Share by Production Technology (2021-2026)
2.4.3.3 Global Famitinib Malate Capsules Sale Price by Production Technology (2021-2026)
2.5 Famitinib Malate Capsules Segment by Sales Channels
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 Famitinib Malate Capsules Sales by Sales Channels
2.5.4.1 Global Famitinib Malate Capsules Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global Famitinib Malate Capsules Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global Famitinib Malate Capsules Sale Price by Sales Channels (2021-2026)
2.6 Famitinib Malate Capsules Segment by Application
2.6.1 Recurrent or Metastatic Cervical Cancer
2.6.2 Advanced Gastrointestinal Tumors
2.6.3 Other Advanced Solid Tumors
2.6.4 Famitinib Malate Capsules Sales by Application
2.6.4.1 Global Famitinib Malate Capsules Sale Market Share by Application (2021-2026)
2.6.4.2 Global Famitinib Malate Capsules Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Famitinib Malate Capsules Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Famitinib Malate Capsules Breakdown Data by Company
3.1.1 Global Famitinib Malate Capsules Annual Sales by Company (2021-2026)
3.1.2 Global Famitinib Malate Capsules Sales Market Share by Company (2021-2026)
3.2 Global Famitinib Malate Capsules Annual Revenue by Company (2021-2026)
3.2.1 Global Famitinib Malate Capsules Revenue by Company (2021-2026)
3.2.2 Global Famitinib Malate Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Famitinib Malate Capsules Sale Price by Company
3.4 Key Manufacturers Famitinib Malate Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Famitinib Malate Capsules Product Location Distribution
3.4.2 Players Famitinib Malate Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FAMITINIB MALATE CAPSULES BY GEOGRAPHIC REGION
4.1 World Historic Famitinib Malate Capsules Market Size by Geographic Region (2021-2026)
4.1.1 Global Famitinib Malate Capsules Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Famitinib Malate Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Famitinib Malate Capsules Market Size by Country/Region (2021-2026)
4.2.1 Global Famitinib Malate Capsules Annual Sales by Country/Region (2021-2026)
4.2.2 Global Famitinib Malate Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Famitinib Malate Capsules Sales Growth
4.4 APAC Famitinib Malate Capsules Sales Growth
4.5 Europe Famitinib Malate Capsules Sales Growth
4.6 Middle East & Africa Famitinib Malate Capsules Sales Growth
5 AMERICAS
5.1 Americas Famitinib Malate Capsules Sales by Country
5.1.1 Americas Famitinib Malate Capsules Sales by Country (2021-2026)
5.1.2 Americas Famitinib Malate Capsules Revenue by Country (2021-2026)
5.2 Americas Famitinib Malate Capsules Sales by Type (2021-2026)
5.3 Americas Famitinib Malate Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Famitinib Malate Capsules Sales by Region
6.1.1 APAC Famitinib Malate Capsules Sales by Region (2021-2026)
6.1.2 APAC Famitinib Malate Capsules Revenue by Region (2021-2026)
6.2 APAC Famitinib Malate Capsules Sales by Type (2021-2026)
6.3 APAC Famitinib Malate Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Famitinib Malate Capsules by Country
7.1.1 Europe Famitinib Malate Capsules Sales by Country (2021-2026)
7.1.2 Europe Famitinib Malate Capsules Revenue by Country (2021-2026)
7.2 Europe Famitinib Malate Capsules Sales by Type (2021-2026)
7.3 Europe Famitinib Malate Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Famitinib Malate Capsules by Country
8.1.1 Middle East & Africa Famitinib Malate Capsules Sales by Country (2021-2026)
8.1.2 Middle East & Africa Famitinib Malate Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Famitinib Malate Capsules Sales by Type (2021-2026)
8.3 Middle East & Africa Famitinib Malate Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Famitinib Malate Capsules
10.3 Manufacturing Process Analysis of Famitinib Malate Capsules
10.4 Industry Chain Structure of Famitinib Malate Capsules
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Famitinib Malate Capsules Distributors
11.3 Famitinib Malate Capsules Customer
12 WORLD FORECAST REVIEW FOR FAMITINIB MALATE CAPSULES BY GEOGRAPHIC REGION
12.1 Global Famitinib Malate Capsules Market Size Forecast by Region
12.1.1 Global Famitinib Malate Capsules Forecast by Region (2027-2032)
12.1.2 Global Famitinib Malate Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Famitinib Malate Capsules Forecast by Type (2027-2032)
12.7 Global Famitinib Malate Capsules Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jiangsu Hengrui Pharmaceutical
13.1.1 Jiangsu Hengrui Pharmaceutical Company Information
13.1.2 Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Product Portfolios and Specifications
13.1.3 Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jiangsu Hengrui Pharmaceutical Main Business Overview
13.1.5 Jiangsu Hengrui Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Famitinib Malate Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Famitinib Malate Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 5 mg per capsule
Table 4. Major Players of 10 mg per capsule
Table 5. Global Famitinib Malate Capsules Sales by Type (2021-2026) & (Units)
Table 6. Global Famitinib Malate Capsules Sales Market Share by Type (2021-2026)
Table 7. Global Famitinib Malate Capsules Revenue by Type (2021-2026) & ($ million)
Table 8. Global Famitinib Malate Capsules Revenue Market Share by Type (2021-2026)
Table 9. Global Famitinib Malate Capsules Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Camrelizumab
Table 11. Major Players of Chemotherapeutic Agents
Table 12. Global Famitinib Malate Capsules Sales by Combination Therapy (2021-2026) & (Units)
Table 13. Global Famitinib Malate Capsules Sales Market Share by Combination Therapy (2021-2026)
Table 14. Global Famitinib Malate Capsules Revenue by Combination Therapy (2021-2026) & ($ million)
Table 15. Global Famitinib Malate Capsules Revenue Market Share by Combination Therapy (2021-2026)
Table 16. Global Famitinib Malate Capsules Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 17. Major Players of Innovator
Table 18. Major Players of Generic
Table 19. Global Famitinib Malate Capsules Sales by Production Technology (2021-2026) & (Units)
Table 20. Global Famitinib Malate Capsules Sales Market Share by Production Technology (2021-2026)
Table 21. Global Famitinib Malate Capsules Revenue by Production Technology (2021-2026) & ($ million)
Table 22. Global Famitinib Malate Capsules Revenue Market Share by Production Technology (2021-2026)
Table 23. Global Famitinib Malate Capsules Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospital
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global Famitinib Malate Capsules Sales by Sales Channels (2021-2026) & (Units)
Table 28. Global Famitinib Malate Capsules Sales Market Share by Sales Channels (2021-2026)
Table 29. Global Famitinib Malate Capsules Revenue by Sales Channels (2021-2026) & ($ million)
Table 30. Global Famitinib Malate Capsules Revenue Market Share by Sales Channels (2021-2026)
Table 31. Global Famitinib Malate Capsules Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 32. Global Famitinib Malate Capsules Sale by Application (2021-2026) & (Units)
Table 33. Global Famitinib Malate Capsules Sale Market Share by Application (2021-2026)
Table 34. Global Famitinib Malate Capsules Revenue by Application (2021-2026) & ($ million)
Table 35. Global Famitinib Malate Capsules Revenue Market Share by Application (2021-2026)
Table 36. Global Famitinib Malate Capsules Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Famitinib Malate Capsules Sales by Company (2021-2026) & (Units)
Table 38. Global Famitinib Malate Capsules Sales Market Share by Company (2021-2026)
Table 39. Global Famitinib Malate Capsules Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Famitinib Malate Capsules Revenue Market Share by Company (2021-2026)
Table 41. Global Famitinib Malate Capsules Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Famitinib Malate Capsules Producing Area Distribution and Sales Area
Table 43. Players Famitinib Malate Capsules Products Offered
Table 44. Famitinib Malate Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Famitinib Malate Capsules Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Famitinib Malate Capsules Sales Market Share Geographic Region (2021-2026)
Table 49. Global Famitinib Malate Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Famitinib Malate Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Famitinib Malate Capsules Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Famitinib Malate Capsules Sales Market Share by Country/Region (2021-2026)
Table 53. Global Famitinib Malate Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Famitinib Malate Capsules Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Famitinib Malate Capsules Sales by Country (2021-2026) & (Units)
Table 56. Americas Famitinib Malate Capsules Sales Market Share by Country (2021-2026)
Table 57. Americas Famitinib Malate Capsules Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Famitinib Malate Capsules Sales by Type (2021-2026) & (Units)
Table 59. Americas Famitinib Malate Capsules Sales by Application (2021-2026) & (Units)
Table 60. APAC Famitinib Malate Capsules Sales by Region (2021-2026) & (Units)
Table 61. APAC Famitinib Malate Capsules Sales Market Share by Region (2021-2026)
Table 62. APAC Famitinib Malate Capsules Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Famitinib Malate Capsules Sales by Type (2021-2026) & (Units)
Table 64. APAC Famitinib Malate Capsules Sales by Application (2021-2026) & (Units)
Table 65. Europe Famitinib Malate Capsules Sales by Country (2021-2026) & (Units)
Table 66. Europe Famitinib Malate Capsules Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Famitinib Malate Capsules Sales by Type (2021-2026) & (Units)
Table 68. Europe Famitinib Malate Capsules Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Famitinib Malate Capsules Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Famitinib Malate Capsules Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Famitinib Malate Capsules Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Famitinib Malate Capsules Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Famitinib Malate Capsules
Table 74. Key Market Challenges & Risks of Famitinib Malate Capsules
Table 75. Key Industry Trends of Famitinib Malate Capsules
Table 76. Famitinib Malate Capsules Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Famitinib Malate Capsules Distributors List
Table 79. Famitinib Malate Capsules Customer List
Table 80. Global Famitinib Malate Capsules Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Famitinib Malate Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Famitinib Malate Capsules Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Famitinib Malate Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Famitinib Malate Capsules Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Famitinib Malate Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Famitinib Malate Capsules Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Famitinib Malate Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Famitinib Malate Capsules Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Famitinib Malate Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Famitinib Malate Capsules Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Famitinib Malate Capsules Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Famitinib Malate Capsules Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Famitinib Malate Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Jiangsu Hengrui Pharmaceutical Basic Information, Famitinib Malate Capsules Manufacturing Base, Sales Area and Its Competitors
Table 95. Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Product Portfolios and Specifications
Table 96. Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Jiangsu Hengrui Pharmaceutical Main Business
Table 98. Jiangsu Hengrui Pharmaceutical Latest Developments
Table 1. Famitinib Malate Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Famitinib Malate Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 5 mg per capsule
Table 4. Major Players of 10 mg per capsule
Table 5. Global Famitinib Malate Capsules Sales by Type (2021-2026) & (Units)
Table 6. Global Famitinib Malate Capsules Sales Market Share by Type (2021-2026)
Table 7. Global Famitinib Malate Capsules Revenue by Type (2021-2026) & ($ million)
Table 8. Global Famitinib Malate Capsules Revenue Market Share by Type (2021-2026)
Table 9. Global Famitinib Malate Capsules Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Camrelizumab
Table 11. Major Players of Chemotherapeutic Agents
Table 12. Global Famitinib Malate Capsules Sales by Combination Therapy (2021-2026) & (Units)
Table 13. Global Famitinib Malate Capsules Sales Market Share by Combination Therapy (2021-2026)
Table 14. Global Famitinib Malate Capsules Revenue by Combination Therapy (2021-2026) & ($ million)
Table 15. Global Famitinib Malate Capsules Revenue Market Share by Combination Therapy (2021-2026)
Table 16. Global Famitinib Malate Capsules Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 17. Major Players of Innovator
Table 18. Major Players of Generic
Table 19. Global Famitinib Malate Capsules Sales by Production Technology (2021-2026) & (Units)
Table 20. Global Famitinib Malate Capsules Sales Market Share by Production Technology (2021-2026)
Table 21. Global Famitinib Malate Capsules Revenue by Production Technology (2021-2026) & ($ million)
Table 22. Global Famitinib Malate Capsules Revenue Market Share by Production Technology (2021-2026)
Table 23. Global Famitinib Malate Capsules Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospital
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global Famitinib Malate Capsules Sales by Sales Channels (2021-2026) & (Units)
Table 28. Global Famitinib Malate Capsules Sales Market Share by Sales Channels (2021-2026)
Table 29. Global Famitinib Malate Capsules Revenue by Sales Channels (2021-2026) & ($ million)
Table 30. Global Famitinib Malate Capsules Revenue Market Share by Sales Channels (2021-2026)
Table 31. Global Famitinib Malate Capsules Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 32. Global Famitinib Malate Capsules Sale by Application (2021-2026) & (Units)
Table 33. Global Famitinib Malate Capsules Sale Market Share by Application (2021-2026)
Table 34. Global Famitinib Malate Capsules Revenue by Application (2021-2026) & ($ million)
Table 35. Global Famitinib Malate Capsules Revenue Market Share by Application (2021-2026)
Table 36. Global Famitinib Malate Capsules Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Famitinib Malate Capsules Sales by Company (2021-2026) & (Units)
Table 38. Global Famitinib Malate Capsules Sales Market Share by Company (2021-2026)
Table 39. Global Famitinib Malate Capsules Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Famitinib Malate Capsules Revenue Market Share by Company (2021-2026)
Table 41. Global Famitinib Malate Capsules Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Famitinib Malate Capsules Producing Area Distribution and Sales Area
Table 43. Players Famitinib Malate Capsules Products Offered
Table 44. Famitinib Malate Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Famitinib Malate Capsules Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Famitinib Malate Capsules Sales Market Share Geographic Region (2021-2026)
Table 49. Global Famitinib Malate Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Famitinib Malate Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Famitinib Malate Capsules Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Famitinib Malate Capsules Sales Market Share by Country/Region (2021-2026)
Table 53. Global Famitinib Malate Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Famitinib Malate Capsules Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Famitinib Malate Capsules Sales by Country (2021-2026) & (Units)
Table 56. Americas Famitinib Malate Capsules Sales Market Share by Country (2021-2026)
Table 57. Americas Famitinib Malate Capsules Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Famitinib Malate Capsules Sales by Type (2021-2026) & (Units)
Table 59. Americas Famitinib Malate Capsules Sales by Application (2021-2026) & (Units)
Table 60. APAC Famitinib Malate Capsules Sales by Region (2021-2026) & (Units)
Table 61. APAC Famitinib Malate Capsules Sales Market Share by Region (2021-2026)
Table 62. APAC Famitinib Malate Capsules Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Famitinib Malate Capsules Sales by Type (2021-2026) & (Units)
Table 64. APAC Famitinib Malate Capsules Sales by Application (2021-2026) & (Units)
Table 65. Europe Famitinib Malate Capsules Sales by Country (2021-2026) & (Units)
Table 66. Europe Famitinib Malate Capsules Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Famitinib Malate Capsules Sales by Type (2021-2026) & (Units)
Table 68. Europe Famitinib Malate Capsules Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Famitinib Malate Capsules Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Famitinib Malate Capsules Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Famitinib Malate Capsules Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Famitinib Malate Capsules Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Famitinib Malate Capsules
Table 74. Key Market Challenges & Risks of Famitinib Malate Capsules
Table 75. Key Industry Trends of Famitinib Malate Capsules
Table 76. Famitinib Malate Capsules Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Famitinib Malate Capsules Distributors List
Table 79. Famitinib Malate Capsules Customer List
Table 80. Global Famitinib Malate Capsules Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Famitinib Malate Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Famitinib Malate Capsules Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Famitinib Malate Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Famitinib Malate Capsules Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Famitinib Malate Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Famitinib Malate Capsules Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Famitinib Malate Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Famitinib Malate Capsules Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Famitinib Malate Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Famitinib Malate Capsules Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Famitinib Malate Capsules Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Famitinib Malate Capsules Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Famitinib Malate Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Jiangsu Hengrui Pharmaceutical Basic Information, Famitinib Malate Capsules Manufacturing Base, Sales Area and Its Competitors
Table 95. Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Product Portfolios and Specifications
Table 96. Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Jiangsu Hengrui Pharmaceutical Main Business
Table 98. Jiangsu Hengrui Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Famitinib Malate Capsules
Figure 2. Famitinib Malate Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Famitinib Malate Capsules Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Famitinib Malate Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Famitinib Malate Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Famitinib Malate Capsules Sales Market Share by Country/Region (2025)
Figure 10. Famitinib Malate Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 5 mg per capsule
Figure 12. Product Picture of 10 mg per capsule
Figure 13. Global Famitinib Malate Capsules Sales Market Share by Type in 2026
Figure 14. Global Famitinib Malate Capsules Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Camrelizumab
Figure 16. Product Picture of Chemotherapeutic Agents
Figure 17. Global Famitinib Malate Capsules Sales Market Share by Combination Therapy in 2026
Figure 18. Global Famitinib Malate Capsules Revenue Market Share by Combination Therapy (2021-2026)
Figure 19. Product Picture of Innovator
Figure 20. Product Picture of Generic
Figure 21. Global Famitinib Malate Capsules Sales Market Share by Production Technology in 2026
Figure 22. Global Famitinib Malate Capsules Revenue Market Share by Production Technology (2021-2026)
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global Famitinib Malate Capsules Sales Market Share by Sales Channels in 2026
Figure 27. Global Famitinib Malate Capsules Revenue Market Share by Sales Channels (2021-2026)
Figure 28. Famitinib Malate Capsules Consumed in Recurrent or Metastatic Cervical Cancer
Figure 29. Global Famitinib Malate Capsules Market: Recurrent or Metastatic Cervical Cancer (2021-2026) & (Units)
Figure 30. Famitinib Malate Capsules Consumed in Advanced Gastrointestinal Tumors
Figure 31. Global Famitinib Malate Capsules Market: Advanced Gastrointestinal Tumors (2021-2026) & (Units)
Figure 32. Famitinib Malate Capsules Consumed in Other Advanced Solid Tumors
Figure 33. Global Famitinib Malate Capsules Market: Other Advanced Solid Tumors (2021-2026) & (Units)
Figure 34. Global Famitinib Malate Capsules Sale Market Share by Application (2025)
Figure 35. Global Famitinib Malate Capsules Revenue Market Share by Application in 2025
Figure 36. Famitinib Malate Capsules Sales by Company in 2025 (Units)
Figure 37. Global Famitinib Malate Capsules Sales Market Share by Company in 2025
Figure 38. Famitinib Malate Capsules Revenue by Company in 2025 ($ millions)
Figure 39. Global Famitinib Malate Capsules Revenue Market Share by Company in 2025
Figure 40. Global Famitinib Malate Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Famitinib Malate Capsules Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Famitinib Malate Capsules Sales 2021-2026 (Units)
Figure 43. Americas Famitinib Malate Capsules Revenue 2021-2026 ($ millions)
Figure 44. APAC Famitinib Malate Capsules Sales 2021-2026 (Units)
Figure 45. APAC Famitinib Malate Capsules Revenue 2021-2026 ($ millions)
Figure 46. Europe Famitinib Malate Capsules Sales 2021-2026 (Units)
Figure 47. Europe Famitinib Malate Capsules Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Famitinib Malate Capsules Sales 2021-2026 (Units)
Figure 49. Middle East & Africa Famitinib Malate Capsules Revenue 2021-2026 ($ millions)
Figure 50. Americas Famitinib Malate Capsules Sales Market Share by Country in 2025
Figure 51. Americas Famitinib Malate Capsules Revenue Market Share by Country (2021-2026)
Figure 52. Americas Famitinib Malate Capsules Sales Market Share by Type (2021-2026)
Figure 53. Americas Famitinib Malate Capsules Sales Market Share by Application (2021-2026)
Figure 54. United States Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Famitinib Malate Capsules Sales Market Share by Region in 2025
Figure 59. APAC Famitinib Malate Capsules Revenue Market Share by Region (2021-2026)
Figure 60. APAC Famitinib Malate Capsules Sales Market Share by Type (2021-2026)
Figure 61. APAC Famitinib Malate Capsules Sales Market Share by Application (2021-2026)
Figure 62. China Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 66. India Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Famitinib Malate Capsules Sales Market Share by Country in 2025
Figure 70. Europe Famitinib Malate Capsules Revenue Market Share by Country (2021-2026)
Figure 71. Europe Famitinib Malate Capsules Sales Market Share by Type (2021-2026)
Figure 72. Europe Famitinib Malate Capsules Sales Market Share by Application (2021-2026)
Figure 73. Germany Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 74. France Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Famitinib Malate Capsules Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Famitinib Malate Capsules Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Famitinib Malate Capsules Sales Market Share by Application (2021-2026)
Figure 81. Egypt Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Famitinib Malate Capsules in 2026
Figure 87. Manufacturing Process Analysis of Famitinib Malate Capsules
Figure 88. Industry Chain Structure of Famitinib Malate Capsules
Figure 89. Channels of Distribution
Figure 90. Global Famitinib Malate Capsules Sales Market Forecast by Region (2027-2032)
Figure 91. Global Famitinib Malate Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Famitinib Malate Capsules Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Famitinib Malate Capsules Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Famitinib Malate Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Famitinib Malate Capsules Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Famitinib Malate Capsules
Figure 2. Famitinib Malate Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Famitinib Malate Capsules Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Famitinib Malate Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Famitinib Malate Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Famitinib Malate Capsules Sales Market Share by Country/Region (2025)
Figure 10. Famitinib Malate Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 5 mg per capsule
Figure 12. Product Picture of 10 mg per capsule
Figure 13. Global Famitinib Malate Capsules Sales Market Share by Type in 2026
Figure 14. Global Famitinib Malate Capsules Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Camrelizumab
Figure 16. Product Picture of Chemotherapeutic Agents
Figure 17. Global Famitinib Malate Capsules Sales Market Share by Combination Therapy in 2026
Figure 18. Global Famitinib Malate Capsules Revenue Market Share by Combination Therapy (2021-2026)
Figure 19. Product Picture of Innovator
Figure 20. Product Picture of Generic
Figure 21. Global Famitinib Malate Capsules Sales Market Share by Production Technology in 2026
Figure 22. Global Famitinib Malate Capsules Revenue Market Share by Production Technology (2021-2026)
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global Famitinib Malate Capsules Sales Market Share by Sales Channels in 2026
Figure 27. Global Famitinib Malate Capsules Revenue Market Share by Sales Channels (2021-2026)
Figure 28. Famitinib Malate Capsules Consumed in Recurrent or Metastatic Cervical Cancer
Figure 29. Global Famitinib Malate Capsules Market: Recurrent or Metastatic Cervical Cancer (2021-2026) & (Units)
Figure 30. Famitinib Malate Capsules Consumed in Advanced Gastrointestinal Tumors
Figure 31. Global Famitinib Malate Capsules Market: Advanced Gastrointestinal Tumors (2021-2026) & (Units)
Figure 32. Famitinib Malate Capsules Consumed in Other Advanced Solid Tumors
Figure 33. Global Famitinib Malate Capsules Market: Other Advanced Solid Tumors (2021-2026) & (Units)
Figure 34. Global Famitinib Malate Capsules Sale Market Share by Application (2025)
Figure 35. Global Famitinib Malate Capsules Revenue Market Share by Application in 2025
Figure 36. Famitinib Malate Capsules Sales by Company in 2025 (Units)
Figure 37. Global Famitinib Malate Capsules Sales Market Share by Company in 2025
Figure 38. Famitinib Malate Capsules Revenue by Company in 2025 ($ millions)
Figure 39. Global Famitinib Malate Capsules Revenue Market Share by Company in 2025
Figure 40. Global Famitinib Malate Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Famitinib Malate Capsules Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Famitinib Malate Capsules Sales 2021-2026 (Units)
Figure 43. Americas Famitinib Malate Capsules Revenue 2021-2026 ($ millions)
Figure 44. APAC Famitinib Malate Capsules Sales 2021-2026 (Units)
Figure 45. APAC Famitinib Malate Capsules Revenue 2021-2026 ($ millions)
Figure 46. Europe Famitinib Malate Capsules Sales 2021-2026 (Units)
Figure 47. Europe Famitinib Malate Capsules Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Famitinib Malate Capsules Sales 2021-2026 (Units)
Figure 49. Middle East & Africa Famitinib Malate Capsules Revenue 2021-2026 ($ millions)
Figure 50. Americas Famitinib Malate Capsules Sales Market Share by Country in 2025
Figure 51. Americas Famitinib Malate Capsules Revenue Market Share by Country (2021-2026)
Figure 52. Americas Famitinib Malate Capsules Sales Market Share by Type (2021-2026)
Figure 53. Americas Famitinib Malate Capsules Sales Market Share by Application (2021-2026)
Figure 54. United States Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Famitinib Malate Capsules Sales Market Share by Region in 2025
Figure 59. APAC Famitinib Malate Capsules Revenue Market Share by Region (2021-2026)
Figure 60. APAC Famitinib Malate Capsules Sales Market Share by Type (2021-2026)
Figure 61. APAC Famitinib Malate Capsules Sales Market Share by Application (2021-2026)
Figure 62. China Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 66. India Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Famitinib Malate Capsules Sales Market Share by Country in 2025
Figure 70. Europe Famitinib Malate Capsules Revenue Market Share by Country (2021-2026)
Figure 71. Europe Famitinib Malate Capsules Sales Market Share by Type (2021-2026)
Figure 72. Europe Famitinib Malate Capsules Sales Market Share by Application (2021-2026)
Figure 73. Germany Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 74. France Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Famitinib Malate Capsules Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Famitinib Malate Capsules Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Famitinib Malate Capsules Sales Market Share by Application (2021-2026)
Figure 81. Egypt Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Famitinib Malate Capsules Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Famitinib Malate Capsules in 2026
Figure 87. Manufacturing Process Analysis of Famitinib Malate Capsules
Figure 88. Industry Chain Structure of Famitinib Malate Capsules
Figure 89. Channels of Distribution
Figure 90. Global Famitinib Malate Capsules Sales Market Forecast by Region (2027-2032)
Figure 91. Global Famitinib Malate Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Famitinib Malate Capsules Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Famitinib Malate Capsules Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Famitinib Malate Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Famitinib Malate Capsules Revenue Market Share Forecast by Application (2027-2032)
